(a)
(b)
(c)
(d)
Figure 5: Effect of YSSXG on the mRNA expression of erythrocyte membrane skeleton protein of patients with thalassemia disease. (a) TEM images of inclusion bodies of α-thalassemia patients of pretreatment. (b) TEM images of inclusion bodies of α-thalassemia patients of posttreatment. (c) TEM images of inclusion bodies of β-thalassemia patients of pretreatment. (d) TEM images of inclusion bodies of β-thalassemia patients of posttreatment.